Skip to main content
ArcherDX teams up with Illumina on IVDs
1/13/2020

A multiyear agreement has been reached by ArcherDX and Illumina to co-market future ArcherDX in vitro diagnostic products with Illumina's NextSeq 550Dx and MiSeq Dx instruments. The partnership is likely to begin with ArcherDX's Stratafide pan-solid tumor test, a companion diagnostic that determines actionable genomic alterations in blood or tissue samples.

Full Story: